These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7288599)

  • 21. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
    Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the antimuscarinic action of p-fluorohexahydrosiladifenidol in ileal and tracheal smooth muscle.
    Ehlert FJ; Hsu JC; Leung K; Lee AG; Shehnaz D; Griffin MT
    J Pharmacol Exp Ther; 2005 Feb; 312(2):592-600. PubMed ID: 15456838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propranolol stereoselectively inhibits alpha-adrenoceptor-mediated vasoconstriction in mesenteric arterial beds of rats.
    Stauber RE; Heinemann A
    J Auton Pharmacol; 1996 Jun; 16(3):125-9. PubMed ID: 8884459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacological method to estimate the pKi of competitive inhibitors of agonist uptake processes in isolated tissues.
    Kenakin TP
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr; 316(2):89-95. PubMed ID: 7242704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some observations on the adrenergic blocking activity of desipramine and amitriptyline on aortic strips of rabbits.
    Scriabine A
    Experientia; 1969 Feb; 25(2):164-5. PubMed ID: 5786092
    [No Abstract]   [Full Text] [Related]  

  • 26. [Calorigenic action of noradrenaline and isoprenaline without and after pretreatment with desipramine].
    Ankermann H
    Biomed Biochim Acta; 1983; 42(10):1327-33. PubMed ID: 6675673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of nonlinear regression to the estimation of in vitro antagonist dissociation constants and relative potency problems.
    Kramer TH
    Proc West Pharmacol Soc; 1991; 34():425-7. PubMed ID: 1788324
    [No Abstract]   [Full Text] [Related]  

  • 28. Drugs and receptors. An overview of the current state of knowledge.
    Kenakin T
    Drugs; 1990 Nov; 40(5):666-87. PubMed ID: 2292230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An alternative method to evaluate the nature of an antagonist and its potency: a theoretical approach.
    Calderone V
    J Pharmacol Toxicol Methods; 1998 Apr; 39(3):129-35. PubMed ID: 9741386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist potency and apparent affinity: interpretation using classical and steady-state ternary-complex models.
    Mackay D
    Trends Pharmacol Sci; 1990 Jan; 11(1):17-22. PubMed ID: 2408209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of agonist affinity, using the slope of the concentration-effect curve: comment on the method of Calderone and Martinotti.
    Van der Graaf PH
    J Pharmacol Toxicol Methods; 1998 Nov; 40(4):241-3. PubMed ID: 10465160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of competitive agonist-antagonist interactions by nonlinear regression.
    Lew MJ; Angus JA
    Trends Pharmacol Sci; 1995 Oct; 16(10):328-37. PubMed ID: 7491710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative version of steady-state ternary-complex model. Agonist potency, affinity and efficacy.
    Mackay D
    Trends Pharmacol Sci; 1990 Mar; 11(3):102-3. PubMed ID: 2104460
    [No Abstract]   [Full Text] [Related]  

  • 34. Errors in agonist affinity estimation: do they and should they occur in isolated tissue experiments?
    Leff P; Dougall IG; Harper DH; Dainty IA
    Trends Pharmacol Sci; 1990 Feb; 11(2):64-7. PubMed ID: 2180161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional characterization and expression of endothelin receptors in rat carotid artery: involvement of nitric oxide, a vasodilator prostanoid and the opening of K+ channels in ETB-induced relaxation.
    Tirapelli CR; Casolari DA; Yogi A; Montezano AC; Tostes RC; Legros E; D'Orléans-Juste P; de Oliveira AM
    Br J Pharmacol; 2005 Nov; 146(6):903-12. PubMed ID: 16151434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of indoramin in rat vas deferens and aorta: concomitant alpha1-adrenoceptor and neuronal uptake blockade.
    Pupo AS; Cavenaghi DL; Campos M; Lucena Morais P; Jurkiewicz NH; Jurkiewicz A
    Br J Pharmacol; 1999 Aug; 127(8):1832-6. PubMed ID: 10482913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depolarizing responses to glycine, beta-alanine and muscimol in isolated optic nerve and cuneate nucleus.
    Simmonds MA
    Br J Pharmacol; 1983 Jul; 79(3):799-806. PubMed ID: 6418249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-Hydroxy-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline (PI-OH): a new potentiator of sympathomimetic amines on the rat anococcygeus muscle.
    Ishida Y; Koga N; Nanbu T; Kihara M; Kobayashi S
    Br J Pharmacol; 1988 May; 94(1):19-26. PubMed ID: 3401637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasoactive responses of a human cystic artery: adrenoceptor characterization.
    Wyse DG
    Br J Clin Pharmacol; 1988 Jun; 25(6):741-9. PubMed ID: 2904823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The measurement of antagonist potency and the importance of selective inhibition of agonist uptake processes.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1981 Oct; 219(1):112-20. PubMed ID: 7288599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.